{"transactions":[{"id":903276,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T01:05:49.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026."}],"balance_after":8450,"derivative":{"exercise_price":0,"expiration_date":"2029-02-13","underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0000875045-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000026/form4.xml","form_type":"4"}},{"id":913130,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":4916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":9834,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":4916},"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913129,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":1940,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1940},"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913128,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 2/8/2023."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2190},"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913127,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1514,"price":201.18,"value":304586.52,"ownership":{"direct":true},"balance_after":41807,"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913126,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":4916,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43321,"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913125,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":931,"price":201.18,"value":187298.58,"ownership":{"direct":true},"balance_after":38405,"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913124,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39336,"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913123,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1059,"price":201.18,"value":213049.62,"ownership":{"direct":true},"balance_after":37396,"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":913122,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:55:45.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38455,"source":{"system":"sec-edgar","filing":"0000875045-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000087504526000015/form4.xml","form_type":"4"}},{"id":1272565,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-12T22:42:23.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2575},"source":{"system":"sec-edgar","filing":"0001127602-25-004454","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004454/form4.xml","form_type":"4"}},{"id":1272564,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:42:23.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":807,"price":142.54,"value":115029.78,"ownership":{"direct":true},"balance_after":36265,"source":{"system":"sec-edgar","filing":"0001127602-25-004454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004454/form4.xml","form_type":"4"}},{"id":1272563,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-12T22:42:23.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37072,"source":{"system":"sec-edgar","filing":"0001127602-25-004454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225004454/form4.xml","form_type":"4"}},{"id":1277515,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":3880,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":1940},"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1277514,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":false,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 2/8/2023."}],"balance_after":2190,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2190},"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1277513,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025."}],"balance_after":14750,"derivative":{"exercise_price":0,"expiration_date":"2028-02-06","underlying":"Common Stock","underlying_shares":14750},"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1277512,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":591,"price":141.35,"value":83537.85,"ownership":{"direct":true},"balance_after":34497,"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1277511,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":1940,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35088,"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1277510,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":643,"price":141.35,"value":90888.05,"ownership":{"direct":true},"balance_after":33148,"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1277509,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-10T23:42:16.000Z","date":"2025-02-07","kind":"exercise","planned":false,"acquired":true,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33791,"source":{"system":"sec-edgar","filing":"0001127602-25-003954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760225003954/form4.xml","form_type":"4"}},{"id":1373431,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-11-07T21:23:10.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":true,"shares":20082,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Susan H. Alexander 2021 Irrevocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to an irrevocable trust for the benefit of the reporting person's children on November 5, 2024. The reporting person's spouse is the trustee of the trust."}],"balance_after":20082,"source":{"system":"sec-edgar","filing":"0001127602-24-026727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224026727/form4.xml","form_type":"4"}},{"id":1373430,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-11-07T21:23:10.000Z","date":"2024-11-05","kind":"gift","planned":false,"acquired":false,"shares":20082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved a gift of securities by the reporting person to an irrevocable trust for the benefit of the reporting person's children on November 5, 2024. The reporting person's spouse is the trustee of the trust."}],"balance_after":31601,"source":{"system":"sec-edgar","filing":"0001127602-24-026727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224026727/form4.xml","form_type":"4"}},{"id":1631007,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"other","planned":false,"acquired":false,"shares":2012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2012},"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1631006,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":1614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 18, 2021. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":2012,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1614},"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1631005,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Performance Stock Unit","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":false,"shares":3423,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3423},"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1631004,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":781,"price":219.08,"value":171101.48,"ownership":{"direct":true},"balance_after":51683,"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1631003,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":1614,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52464,"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1631002,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1656,"price":219.08,"value":362796.48,"ownership":{"direct":true},"balance_after":50850,"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1631001,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-22T02:39:56.000Z","date":"2024-02-16","kind":"exercise","planned":false,"acquired":true,"shares":3423,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52506,"source":{"system":"sec-edgar","filing":"0001127602-24-006220","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224006220/form4.xml","form_type":"4"}},{"id":1647454,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T22:56:38.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":false,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":2575,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2575},"source":{"system":"sec-edgar","filing":"0001127602-24-004786","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004786/form4.xml","form_type":"4"}},{"id":1647453,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-13T22:56:38.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":938,"price":240.98,"value":226039.24,"ownership":{"direct":true},"balance_after":49083,"source":{"system":"sec-edgar","filing":"0001127602-24-004786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004786/form4.xml","form_type":"4"}},{"id":1647452,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-13T22:56:38.000Z","date":"2024-02-09","kind":"exercise","planned":false,"acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50021,"source":{"system":"sec-edgar","filing":"0001127602-24-004786","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004786/form4.xml","form_type":"4"}},{"id":1652234,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:16:49.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 2/8/2023."}],"balance_after":4380,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":2190},"source":{"system":"sec-edgar","filing":"0001127602-24-004311","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004311/form4.xml","form_type":"4"}},{"id":1652233,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-10T01:16:49.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024."}],"balance_after":5820,"derivative":{"exercise_price":0,"expiration_date":"2027-02-07","underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001127602-24-004311","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004311/form4.xml","form_type":"4"}},{"id":1652232,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-10T01:16:49.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":655,"price":240.3,"value":157396.5,"ownership":{"direct":true},"balance_after":47446,"source":{"system":"sec-edgar","filing":"0001127602-24-004311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004311/form4.xml","form_type":"4"}},{"id":1652231,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-10T01:16:49.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48101,"source":{"system":"sec-edgar","filing":"0001127602-24-004311","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224004311/form4.xml","form_type":"4"}},{"id":1665786,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Officer"}}],"security":"Performance Stock Unit","published_at":"2024-01-31T22:27:31.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":3423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 18, 2021. The PSUs will vest on February 18, 2024."}],"balance_after":3423,"derivative":{"exercise_price":0,"exercise_date":"2024-02-18","expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":3423},"source":{"system":"sec-edgar","filing":"0001127602-24-002799","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760224002799/form4.xml","form_type":"4"}},{"id":2001561,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T21:49:49.000Z","date":"2023-02-17","kind":"other","acquired":false,"shares":1702,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":3626,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1702},"source":{"system":"sec-edgar","filing":"0001127602-23-006502","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006502/form4.xml","form_type":"4"}},{"id":2001560,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-02-22T21:49:49.000Z","date":"2023-02-17","kind":"exercise","acquired":false,"shares":1920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":5328,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1920},"source":{"system":"sec-edgar","filing":"0001127602-23-006502","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006502/form4.xml","form_type":"4"}},{"id":2001559,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-22T21:49:49.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":929,"price":278.38,"value":258615.02,"ownership":{"direct":true},"balance_after":45911,"source":{"system":"sec-edgar","filing":"0001127602-23-006502","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006502/form4.xml","form_type":"4"}},{"id":2001558,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-22T21:49:49.000Z","date":"2023-02-17","kind":"exercise","acquired":true,"shares":1920,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":46840,"source":{"system":"sec-edgar","filing":"0001127602-23-006502","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223006502/form4.xml","form_type":"4"}},{"id":2017940,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"other","acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017939,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":1448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted to the reporting person on February 12, 2020. The number of RSUs reported represented the maximum possible number of shares that were eligible for vesting, which is 200% of the number of shares at target\npayout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common\nstock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing\nstock price following and including the grant date])."}],"balance_after":1770,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1448},"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017938,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"exercise","acquired":false,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":5150,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":2575},"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017937,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":2737,"price":286.3,"value":783603.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 27, 2023."}],"balance_after":44920,"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017936,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":701,"price":286.3,"value":200696.3,"ownership":{"direct":true},"balance_after":47657,"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017935,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":1448,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48358,"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017934,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":764,"price":286.3,"value":218733.2,"ownership":{"direct":true},"balance_after":46910,"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2017933,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-02-15T02:46:39.000Z","date":"2023-02-10","kind":"exercise","acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":47674,"source":{"system":"sec-edgar","filing":"0001127602-23-005273","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223005273/form4.xml","form_type":"4"}},{"id":2023664,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T23:42:51.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":6570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 2/8/2023."}],"balance_after":6570,"derivative":{"exercise_price":0,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":6570},"source":{"system":"sec-edgar","filing":"0001127602-23-004573","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223004573/form4.xml","form_type":"4"}},{"id":2044271,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2023-01-27T22:52:08.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":5703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2020. The shares will vest on February 12, 2023."}],"balance_after":45099,"source":{"system":"sec-edgar","filing":"0001127602-23-002477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760223002477/form4.xml","form_type":"4"}},{"id":2130680,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-10-28T23:19:12.000Z","date":"2022-10-27","kind":"sale","acquired":false,"shares":5532,"price":280.7,"value":1552832.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":39396,"source":{"system":"sec-edgar","filing":"0001127602-22-024470","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222024470/form4.xml","form_type":"4"}},{"id":2306517,"issuer":{"id":86444,"kind":"organization","name":"INVACARE HOLDINGS Corp","symbol":"IVC"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-04-05T16:35:20.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":39474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3.  These restricted stock units vest in full on May 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,388 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan, all of which vest in full on May 15, 2022."}],"balance_after":104499,"source":{"system":"sec-edgar","filing":"0001209191-22-023051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742112/000120919122023051/doc4.xml","form_type":"4"}},{"id":2380132,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:14:06.000Z","date":"2022-02-18","kind":"other","acquired":false,"shares":2137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":7248,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":2137},"source":{"system":"sec-edgar","filing":"0001127602-22-006262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006262/form4.xml","form_type":"4"}},{"id":2380131,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-23T21:14:06.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":1485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":9385,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":1485},"source":{"system":"sec-edgar","filing":"0001127602-22-006262","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006262/form4.xml","form_type":"4"}},{"id":2380130,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-23T21:14:06.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":659,"price":209.79,"value":138251.61,"ownership":{"direct":true},"balance_after":44928,"source":{"system":"sec-edgar","filing":"0001127602-22-006262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006262/form4.xml","form_type":"4"}},{"id":2380129,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-23T21:14:06.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":1485,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45587,"source":{"system":"sec-edgar","filing":"0001127602-22-006262","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222006262/form4.xml","form_type":"4"}},{"id":2395654,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":2090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":3218,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":2090},"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395653,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":1126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":5308,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1126},"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395652,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"other","acquired":false,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":2190},"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395651,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"exercise","acquired":false,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":2190,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1154},"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395650,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":1044,"price":214.59,"value":224031.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon vesting of shares, as previously disclosed by reporting person on January 21, 2022."}],"balance_after":44102,"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395649,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":500,"price":214.59,"value":107295.0,"ownership":{"direct":true},"balance_after":45146,"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395648,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":1126,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45646,"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395647,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"tax_withholding","acquired":false,"shares":512,"price":214.59,"value":109870.08,"ownership":{"direct":true},"balance_after":44520,"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2395646,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-02-15T21:17:24.000Z","date":"2022-02-12","kind":"exercise","acquired":true,"shares":1154,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45032,"source":{"system":"sec-edgar","filing":"0001127602-22-004993","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004993/form4.xml","form_type":"4"}},{"id":2399484,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2022-02-14T21:29:36.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":7725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022."}],"balance_after":7725,"derivative":{"exercise_price":0,"expiration_date":"2025-02-10","underlying":"Common Stock","underlying_shares":7725},"source":{"system":"sec-edgar","filing":"0001127602-22-004811","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222004811/form4.xml","form_type":"4"}},{"id":2429257,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-01-21T21:44:46.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":2825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019.  The shares will vest on February 12, 2022."}],"balance_after":43878,"source":{"system":"sec-edgar","filing":"0001127602-22-001858","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222001858/form4.xml","form_type":"4"}},{"id":2429256,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2022-01-21T21:44:46.000Z","date":"2021-08-09","kind":"gift","acquired":false,"shares":523,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41053,"source":{"system":"sec-edgar","filing":"0001127602-22-001858","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222001858/form4.xml","form_type":"4"}},{"id":2788112,"issuer":{"id":86444,"kind":"organization","name":"INVACARE HOLDINGS Corp","symbol":"IVC"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-03-16T16:39:02.000Z","date":"2021-03-12","kind":"grant","acquired":true,"shares":13388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3.  These restricted stock units vest in full on May 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,439 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan, all of which vest in full on May 15, 2021."}],"balance_after":65025,"source":{"system":"sec-edgar","filing":"0001209191-21-020835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742112/000120919121020835/doc4.xml","form_type":"4"}},{"id":2844478,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-22T21:04:29.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":10870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":10870,"derivative":{"exercise_price":0,"expiration_date":"2024-02-18","underlying":"Common Stock","underlying_shares":10870},"source":{"system":"sec-edgar","filing":"0001127602-21-006970","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006970/form4.xml","form_type":"4"}},{"id":2856299,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":1367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":6434,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1367},"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856298,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":1849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":7801,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":1849},"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856297,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":3344,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1402},"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856296,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":1936,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":4746,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1936},"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856295,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"other","acquired":false,"shares":1788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":1788},"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856294,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout.  One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date.  The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1788,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":1586},"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856293,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":607,"price":278.03,"value":168764.21,"ownership":{"direct":true},"balance_after":41576,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856292,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":622,"price":278.03,"value":172934.66,"ownership":{"direct":true},"balance_after":42183,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856291,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":704,"price":278.03,"value":195733.12,"ownership":{"direct":true},"balance_after":42805,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856290,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":1367,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43509,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856289,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":1402,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42142,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856288,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40740,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2856287,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-02-17T21:52:21.000Z","date":"2021-02-12","kind":"tax_withholding","acquired":false,"shares":1963,"price":278.03,"value":545772.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to satisfy the withholding tax liability due upon the vesting of shares, as previously disclosed by reporting person on January 29, 2021."}],"balance_after":39154,"source":{"system":"sec-edgar","filing":"0001127602-21-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221006261/form4.xml","form_type":"4"}},{"id":2891221,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2021-01-29T21:47:04.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":4545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2018.  The shares will vest on February 12, 2021."}],"balance_after":41117,"source":{"system":"sec-edgar","filing":"0001127602-21-002980","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221002980/form4.xml","form_type":"4"}},{"id":3191755,"issuer":{"id":86444,"kind":"organization","name":"INVACARE HOLDINGS Corp","symbol":"IVC"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-03-31T17:14:14.000Z","date":"2020-03-27","kind":"grant","acquired":true,"shares":15439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units granted pursuant to the Invacare Corporation 2018 Equity Compensation Plan in an exempt transaction under Rule 16b-3.  These restricted stock units vest in full on May 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 18,045 previously reported restricted stock units issued pursuant to the Invacare Corporation 2018 Equity Compensation Plan, all of which vest in full on May 15, 2020."}],"balance_after":51637,"source":{"system":"sec-edgar","filing":"0001209191-20-021855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/742112/000120919120021855/doc4.xml","form_type":"4"}},{"id":3264783,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-19T23:09:24.000Z","date":"2020-02-15","kind":"other","acquired":false,"shares":1171,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":1171},"source":{"system":"sec-edgar","filing":"0001127602-20-006544","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006544/form4.xml","form_type":"4"}},{"id":3264782,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-19T23:09:24.000Z","date":"2020-02-15","kind":"exercise","acquired":false,"shares":1553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1171,"derivative":{"exercise_price":0,"expiration_date":"2020-02-15","underlying":"Common Stock","underlying_shares":1553},"source":{"system":"sec-edgar","filing":"0001127602-20-006544","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006544/form4.xml","form_type":"4"}},{"id":3264781,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2020-02-19T23:09:24.000Z","date":"2020-02-15","kind":"tax_withholding","acquired":false,"shares":689,"price":333,"value":229437.0,"ownership":{"direct":true},"balance_after":36572,"source":{"system":"sec-edgar","filing":"0001127602-20-006544","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006544/form4.xml","form_type":"4"}},{"id":3264780,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2020-02-19T23:09:24.000Z","date":"2020-02-15","kind":"exercise","acquired":true,"shares":1553,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37261,"source":{"system":"sec-edgar","filing":"0001127602-20-006544","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220006544/form4.xml","form_type":"4"}},{"id":3272315,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":1803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":6682,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1803},"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272314,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":8485,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1535},"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272313,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":2697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units will vest in 2 annual installments.  One-third will vest on the first anniversary of the grant date and two-thirds will vest on the second anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2020-02-12","underlying":"Common Stock","underlying_shares":2697},"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272312,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":3374,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":1633},"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272311,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":1735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":5007,"derivative":{"exercise_price":0,"expiration_date":"2021-02-12","underlying":"Common Stock","underlying_shares":1735},"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272310,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":9650,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272309,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":681,"price":331.76,"value":225928.56,"ownership":{"direct":true},"balance_after":35708,"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272308,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":1535,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36389,"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272307,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":798,"price":331.76,"value":264744.48,"ownership":{"direct":true},"balance_after":34854,"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}},{"id":3272306,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":66324,"kind":"person","name":"ALEXANDER SUSAN H","position":1,"cik":"0001263839","reported_name":"ALEXANDER SUSAN H","relationship":{"officer":true,"officer_title":"EVP Chief Legal Off & Corp Sec"}}],"security":"Common Stock","published_at":"2020-02-14T23:25:04.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":2697,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35652,"source":{"system":"sec-edgar","filing":"0001127602-20-005772","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005772/form4.xml","form_type":"4"}}],"next_cursor":"2020-02-14T23:25:04.000000Z,3272306"}